| Literature DB >> 35921221 |
Rubén M Carballo1, José M Padrón2, Israel Fernández3, Daniel A Cruz4, Luana Grmuša4, Víctor S Martín2, Juan I Padrón4.
Abstract
A direct, catalytic, and complementary method to obtain 2-substituted homoallyl sulfonyl amides is described, starting from sulfonyl amides, aldehydes, and allyltrimethylsilane using iron(III) chloride as a sustainable catalyst. The scope of the process and the reactivity in aza-Prins cyclization is evaluated and supported by density functional theory (DFT) studies. Finally, an evaluation of the antiproliferative activity for this family of sulfonyl amides is also included.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35921221 PMCID: PMC9396664 DOI: 10.1021/acs.joc.2c01267
Source DB: PubMed Journal: J Org Chem ISSN: 0022-3263 Impact factor: 4.198
Figure 12-Substituted homoallyl sulfonyl amides as precursors of 4-halo-2,6-disubstituted piperidine in aza-Prins annulation.
Scheme 1Approach to 4-Chloro-2,6-disubstituted Piperidine
Scheme 2Anomalous Results in the Approach to 4-Chloro-2,6-disubstituted Piperidine
Scheme 3Proposed Mechanism of the Frustrated Aza-Prins Cyclization with α-Substituted Homoallyl Sulfonyl amides
Figure 2Computed reaction profile for the formation of pyrans. Relative electronic energies (ZPVE included) and bond distances are given in kcal/mol and angstroms, respectively. All data have been computed at the PCM(CH2Cl2)-M06-2X/def2-SVP level.
Scheme 4Aza-Prins Cyclization with Formaldehyde from 2-Substituted Homoallyl Sulfonyl Amides
Optimization of the Iron-Catalyzed One-Pot Synthesis of 2-Substituted Homoallyl Sulfonyl Amides
| entry | FeX3 (mol %) | MgSO4 (equiv) | TsNH2 (equiv) | TMSCl (equiv) | temperature (°C) | time | yield | |
|---|---|---|---|---|---|---|---|---|
| 1 | Cl | 5 (a), 5 (b) | 1.5 | rt (a), rt (b) | 7 | 60 | ||
| 2 | Cl | 5 (a), 5 (b) | 1.5 | rt (a), rt (b) | 7 | 65 | ||
| 3 | Cl | 5 (a), 5 (b) | 1.0 | 1.5 | 50 (a), rt (b) | 7 | 70 | |
| 4 | Cl | 5 (a), 5 (b) | 1.0 | 1.5 | 50 (a), 0 (b) | 7 | 75 | |
| 5 | Cl | 5 (a), 10 (b) | 1.0 | 1.5 | 50 (a), 0 (b) | 6 | 80 | |
| 6 | Cl | 10 (a), 5 (b) | 1.0 | 1.5 | 50 (a), 0 (b) | 6 | 82 | |
| 7 | Cl | 10 (a), 10 (b) | 1.0 | 1.5 | 50 (a), 0 (b) | 5 | 90 | |
| 8 | Cl | 10 (a), 10 (b) | 1.5 | 1.0 (a) | 50 (a), 0 (b) | 5 | 80 | |
| 9 | Cl | 10 (a), 10 (b) | 1.5 | 1.0 (b) | 50 (a), 0 (b) | 5 | 78 | |
| 10 | Cl | 10 (a), 10 (b) | 1.5 | 1.0 (a, b) | 50 (a), 0 (b) | 5 | 83 | |
| 11 | acac | 10 (a), 10 (b) | 1.5 | 50 (a), 0 (b) | 24 | 0 | ||
| 12 | acac | 10 (a), 10 (b) | 1.5 | 1.0 (b) | 50 (a), 0 (b) | 24 | 0 | |
| 13 | acac | 10 (a), 10 (b) | 1.5 | 1.0 (a) | 50 (a), 0 (b) | 12 | 30 | |
| 14 | acac | 10 (a), 10 (b) | 1.5 | 1.0 (a, b) | 50 (a), 0 (b) | 12 | 60 |
Conditions: 1 (4.2 mmol), 2 (2.8 mmol), FeCl3 (10 mol %), CH2Cl2 (0.3 M), MgSO4 (4.2 mmol), or TMSCl (4.2 mmol), reflux during 2 h, then FeCl3 (10 mol %), allyl trimethyl silane (2.8 mmol) at 0 °C.
Isolated yields.
0.1 M in CH2Cl2.
Includes 0.5 h for step a.
Scope of the One-Pot Synthesis of 2-Substituted Homoallyl Sulfonyl Amides
| entry | product | yield (%) | yield reported (%) | ||
|---|---|---|---|---|---|
| 1 | Ph | Ts | 90 | 94 (86) | |
| 2 | 1-Naph | Ts | 85 | 81 | |
| 3 | Ts | 65 | 93 | ||
| 4 | Ts | 75 | 73 | ||
| 5 | Ts | 85 | 79 | ||
| 6 | Ts | 87 | |||
| 7 | Ts | 87 | |||
| 8 | Ts | 60 | |||
| 9 | Ts | 78 | |||
| 10 | Ts | 67 | |||
| 11 | Ts | 80 | |||
| 12 | Ts | 16 | |||
| 13 | Ph | Ms | 77 | 72 (70) | |
| 14 | Ms | 60 | |||
| 15 | Ms | 75 | |||
| 16 | Ms | 69 | |||
| 17 | Ms | 20 | |||
| 18 | Ms | 0 | |||
| 19 | Ms | 0 | |||
| 20 | Ph | Ns | 0 | ||
| 21 | Naph | Ns | 0 |
Conditions: 1 (4.2 mmol), 2 (2.8 mmol), FeCl3 (10 mol %), CH2Cl2 (0.3 M), MgSO4 (4.2 mmol), or TMSCl (4.2 mmol), reflux during 2 h, then FeCl3 (10 mol %), allyltrimethyl silane (2.8 mmol) at 0 °C.
Isolated yields.
(In parentheses, the yields obtained in our hands).
Scheme 52-Substituted Homoallyl Tosylamides with the Best in Vitro Antiproliferative Activity against the Human Solid Tumor Cell Lines A2780, HBL-100, HeLa, SW1573, T-47D, and WiDr